University of Maryland students might pay for an Uber ride home after a night out in College Park. Now, Uber’s about to pay them.
The company will invest $25,000 over the next two years in student-run startups at the University of Maryland, College Park, one of only three college partnerships for the San Francisco-based ride-share company, the university announced Sunday.
Just because startup incubators don’t employ dozens of people directly, that doesn’t mean they shouldn’t be eligible for the same economic development tax credit other spaces get.
That’s the argument two Baltimore-based state lawmakers are making with a pair of bills that were heard in Annapolis during the current legislative session.
Photo by Flickr user Maryland GovPics, used under a Creative Commons license
A new diet known by the acronym MIND (Mediterranean-DASH Intervention for Neurodegenerative Delay) could significantly lower a person’s risk of developing Alzheimer’s disease (AD) — even if the diet is not meticulously followed, according to a paper published in the journal Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association.
This finding comes from a longitudinal study by Rush University Medical Center and Harvard School of Public Health of 923 volunteers (144 of them developed AD) shows that the MIND diet lowered the risk of AD by as much as 53 percent in participants who adhered to the diet rigorously, and by about 35 percent in those who followed it moderately well.
The NCI Technology Transfer Center offers fellowships under the Cancer Research Training Award (CRTA) program. These fellowships provide people having advanced degrees with training and mentored work experience in technology transfer. For more information on the TTC Fellowship:
Oak Investment Partners, New Enterprise Associates and Revolution should be familiar players now to those companies in Maryland looking to get venture capital funding.
All three were in the top 10 in terms of firms that invested in Maryland companies in 2013; this year, all three made the top five, along with two newcomers. The information comes from our List of Venture Capital Firms that invested in Maryland companies in 2014.
MedImmune, the global biologics research and development arm of AstraZeneca, today announced that it has entered into a new five year Scientific and Technological Cooperation Agreement with the São Paulo Research Foundation (FAPESP), an independent public foundation with the mission to foster research and the scientific and technological development of the State of São Paulo in Brazil. This collaboration, which is the result of a cross-functional effort among MedImmune, AstraZeneca Brazil, and the State of São Paulo, will focus on identifying and accessing the best science and scientists in the cardiovascular and metabolic disease areas at São Paulo’s public and private research institutions.
Nimbus Therapeutics will have $43 million to progress clinical trials of its non-alcoholic liver disease drug after the company successfully completed a financing round.
The Series B investment was led by Pfizer Venture Investments and Lightstone Ventures. Previous investors, including Atlas Venture, SR One, Lilly Ventures and Bill Gates, also participated.
Juan González sees one glaring difference between Spain and the U.S.
Just like America, Spain has plenty of ideas, entrepreneurs, investors and even accelerators to support startups.
MdBio Foundation is hosting ATLAS College + Career STEM Symposium. This event targets high school upperclassmen and college undergraduates from backgrounds typically underrepresented in STEM.
ATLAS needs STEM professionals and graduate students to participate in upcoming events. Please contact Erica Smith if you would like to volunteer or for additional details.
Limited sponsorship packages are still available to support this highly successful program and other MdBio Foundation initiatives. Contact Brian Gaines to learn more.
The Maryland Technology Development Corporation (TEDCO) announced today that three Maryland companies received funding from its Cybersecurity Investment Fund (CIF). Strajillion, Protenus, and Ridgeback are the first three companies, each receiving $100,000, through CIF. The Fund supports Maryland companies develop and commercialize new cybersecurity products or services by providing investments of up to $100,000.
“CIF is the first dedicated cybersecurity fund created in the State to help establish Maryland as the innovation hub of information security,” said Rob Rosenbaum, president and executive director of TEDCO. “We are extremely pleased to have funded these companies and believe they have created very unique products and with the financial support from CIF, are confident they can accelerate their development and commercial launch.”
